Role of Cannabinoid Receptors in Crocin-Induced Hypoalgesia in Neuropathic Pain in Rats

References

• Deleo JA, Tanga FY, Tawfik VL. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist. 2004;10(1):40–52. doi:10.1177/1073858403259950
   PubMed Web of Science ®Google Scholar
• Vakili A, Shirvanian M, Safakhah H, Rashidy-Pour A. Pentoxifylline decreases allodynia and hyperalgesia in a rat model of neuropathic pain. Daru. 2011;19(4):306–311.
   Web of Science ®Google Scholar
• Safakhah HA, Bazargani A, Ghanbari A. Effects of forced exercise on neuropathic pain induced by chronic constriction injury of sciatic nerve in male rat. Koomesh. 2016;411–418.
   Google Scholar
• Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist. 2010;16(5):519–531. doi:10.1177/1073858409360822
   Web of Science ®Google Scholar
• Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003;2(12):973–985. doi:10.1038/nrd1251
   PubMed Web of Science ®Google Scholar
• Mohamadpour AH, Ayati Z, Parizadeh MR, Rajbai O, Hosseinzadeh H. Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iran J Basic Med Sci. 2013;16(1):39.
   PubMed Web of Science ®Google Scholar
• Rios J, Recio M, Giner R, Manez S. An update review of saffron and its active constituents. Phytother Res. 1996;10(3):189–193. doi:10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C
   Web of Science ®Google Scholar
• Arefzadeh N, Arshami MH, Mousavi effects of aqueous and alcohol extracts of saffron(Crocus sativus L.) on blood analysis of rats. Paper presented at: therapeutic plants congress; 2012.
   Google Scholar
• Abdullaev F, Riveron-Negrete L, Caballero-Ortega H, et al. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol in Vitro. 2003;17(5–6):731–736. doi:10.1016/S0887-2333(03)00098-5
   Web of Science ®Google Scholar
• Premkumar K, Abraham SK, Santhiya ST, Gopinath PM, Ramesh A. Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug Chem Toxicol. 2001;24(4):421–428. doi:10.1081/DCT-100106266
   PubMed Web of Science ®Google Scholar
• Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007;157(13–14):315–319. doi:10.1007/s10354-007-0428-4
   PubMedGoogle Scholar
• Kubo I, Kinst-Hori I. Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. J Agric Food Chem. 1999;47(10):4121–4125. doi:10.1021/jf990201q
   PubMed Web of Science ®Google Scholar
• Tamaddonfard E, Farshid AA, Eghdami K, Samadi F, Erfanparast A. Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats. Pharmacol Rep. 2013;65(5):1272–1280. doi:10.1016/S1734-1140(13)71485-3
   Web of Science ®Google Scholar
• Safakhah HA, Damghanian F, Bandegi AR, Miladi-Gorji H. Effect of crocin on morphine tolerance and serum BDNF levels in a rat model of neuropathic pain. Pharmacol Rep. 2020;72(2):305–313. doi:10.1007/s43440-020-00071-9
   Web of Science ®Google Scholar
• Bridges D, Ahmad K, Rice AS. The synthetic cannabinoid WIN55, 212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol. 2001;133(4):586–594. doi:10.1038/sj.bjp.0704110
   PubMed Web of Science ®Google Scholar
• Safakhah HA, Taghavi T, Rashidy-Pour A, et al. Effects of saffron (Crocus sativus L.) stigma extract and its active constituent crocin on neuropathic pain responses in a rat model of chronic constriction injury. Iran J Pharm Res. 2016;15(1):253.
   Web of Science ®Google Scholar
• Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012;83(5):888–895. doi:10.1016/j.fitote.2012.03.022
   PubMed Web of Science ®Google Scholar
• Karami M, Bathaie SZ, Tiraihi T, Habibi-Rezaei M, Arabkheradmand J, Faghihzadeh S. Crocin improved locomotor function and mechanical behavior in the rat model of contused spinal cord injury through decreasing calcitonin gene related peptide (CGRP). Phytomedicine. 2013;21(1):62–67. doi:10.1016/j.phymed.2013.07.013
   Web of Science ®Google Scholar
• Mechoulam R, Shabat SB, Hanuš L, et al. Endogenous cannabinoid ligands—chemical and biological studies. J Lipid Mediat Cell Signal. 1996;14(1):45–49. doi:10.1016/0929-7855(96)01507-6
   Google Scholar
• Palazzo E, Luongo L, Bellini G, et al. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. CNS Neurol Disord Drug Targets. 2012;11(2):148–161.
   Web of Science ®Google Scholar
• Toniolo EF, Maique ET, Jr WA F, et al. Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides. 2014;56:125–131. doi:10.1016/j.peptides.2014.03.016
   Web of Science ®Google Scholar
• Svíženská IH, Brázda V, Klusáková I, Dubový P. Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model. J Histochem Cytochem. 2013;61(7):529–547. doi:10.1369/0022155413491269
   Web of Science ®Google Scholar
• Maccarone R, Rapino C, Zerti D, et al. Modulation of Type-1 and Type-2 cannabinoid receptors by saffron in a rat model of retinal neurodegeneration. PLoS One. 2016;11(11):e0166827. doi:10.1371/journal.pone.0166827
   Web of Science ®Google Scholar
• Vakili A, Einali MR, Bandegi AR. Protective effect of crocin against cerebral ischemia in a dose-dependent manner in a rat model of ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(1):106–113. doi:10.1016/j.jstrokecerebrovasdis.2012.10.008
   PubMed Web of Science ®Google Scholar
• Dogrul A, Gul H, Akar A, Yildiz O, Bilgin F, Guzeldemir E. Topical cannabinoid antinociception: synergy with spinal sites. Pain. 2003;105(1–2):11–16. doi:10.1016/S0304-3959(03)00068-X
   PubMed Web of Science ®Google Scholar
• Fernandez-Solari J, Prestifilippo JP, Vissio P, et al. Anandamide injected into the lateral ventricle of the brain inhibits submandibular salivary secretion by attenuating parasympathetic neurotransmission. Braz J Med Biol Res. 2009;42(6):537–544.
   Web of Science ®Google Scholar
• Deshmukh R, Sharma P. Activation of central cannabinoid CB1 receptors by WIN 55, 212-2 induces hyperphagia and facilitates preferential increase in palatable diet consumption in Wistar rats. Int J Recent Adv Pharm Res. 2012;2:62–69.
   Google Scholar
• Goonawardena AV, Plano A, Robinson L, Platt B, Hampson RE, Riedel G. A pilot study into the effects of the CB1 cannabinoid receptor agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on sleep in rats. Sleep Disord. 2011;2011:178469. doi:10.1155/2011/178469
   Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107. doi:10.1016/0304-3959(88)90209-6
   PubMed Web of Science ®Google Scholar
• Seyer B, Pham V, Albiston AL, Chai SY. Cannula implantation into the lateral ventricle does not adversely affect recognition or spatial working memory. Neurosci Lett. 2016;628:171–178. doi:10.1016/j.neulet.2016.06.034
   Web of Science ®Google Scholar
• Paxinos G, Watson CR. The Rat Brain in Stereotaxic Coordinates. 5th ed. Orlando, FL: Academic Press; 2005.
   Google Scholar
• Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav. 1999;67(5):711–716. doi:10.1016/S0031-9384(99)00136-5
   PubMed Web of Science ®Google Scholar
• Chaplan SR, Bach F, Pogrel J, Chung J, Yaksh T. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-9
   PubMed Web of Science ®Google Scholar
• Safakhah HA, Tamimi F, Bandegi AR, Ghanbari A. Hypoalgesic effect of Spirulina platensis on the sciatic neuropathic pain induced by chronic constriction injury in male rats. Biomed Res Ther. 2018;5(9):2671–2679. doi:10.15419/bmrat.v5i9.477
   Web of Science ®Google Scholar
• Noorbala AA, Tahmasebipour N, et al. Effects of saffron (Crocus sativus L.) on mild to moderate depression; A double blinded clinical trial. J Med Plant. 2004;2(10):31–38.
   Google Scholar
• Patel S, Sarwat M, Khan TH. Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): the molecular perspective. Crit Rev Oncol Hematol. 2017;115:27–35. doi:10.1016/j.critrevonc.2017.04.010
   PubMed Web of Science ®Google Scholar
• Bisti S, Maccarone R, Falsini B. Saffron and retina: neuroprotection and pharmacokinetics. Vis Neurosci. 2014;31(4–5):355–361. doi:10.1017/S0952523814000108
   Web of Science ®Google Scholar
• Tabatabai SM, Dashti S, Doosti F, Hosseinzadeh H. Phytotherapy of opioid dependence and withdrawal syndrome: a review. Phytother Res. 2014;28(6):811–830. doi:10.1002/ptr.5073
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh H, Modaghegh MH, Saffari Z. Crocus sativus L. (Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evid Based Complement Alternat Med. 2009;6(3):343–350. doi:10.1093/ecam/nem125
   PubMed Web of Science ®Google Scholar
• Ghasemi T, Abnous K, Vahdati F, Mehri S, Razavi BM, Hosseinzadeh H. Antidepressant effect of crocus sativus aqueous extract and its effect on CREB, BDNF, and VGF transcript and protein levels in rat hippocampus. Drug Res. 2015;65(7):337–343. doi:10.1055/s-0034-1371876
   Google Scholar
• Mehri S, Abnous K, Mousavi SH, Shariaty VM, Hosseinzadeh H. Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32(2):227–235. doi:10.1007/s10571-011-9752-8
   PubMed Web of Science ®Google Scholar
• Sani AM, Tajali F, Gazrani S. Role of solvent concentration on qualitative efficacy of saffron(crocus sativus) oral remedy. Natl Congr Ther Plant Nat Prod. 2013;1(1).
   Google Scholar
• Costa B, Colleoni M, Conti S, et al. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br J Pharmacol. 2004;141(1):4–8. doi:10.1038/sj.bjp.0705587
   Web of Science ®Google Scholar
• Dani M, Guindon J, Lambert C, Beaulieu P. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol. 2007;573(1–3):214–215. doi:10.1016/j.ejphar.2007.07.012
   PubMed Web of Science ®Google Scholar
• Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain. 2005;116(1–2):52–61. doi:10.1016/j.pain.2005.03.043
   PubMed Web of Science ®Google Scholar
• Nam KN, Park YM, Jung HJ, et al. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol. 2010;648(1–3):110–116. doi:10.1016/j.ejphar.2010.09.003
   PubMed Web of Science ®Google Scholar
• Bandegi AR, Rashidy-Pour A, Vafaei AA, Ghadrdoost B. Protective effects of crocus sativus L. extract and crocin against chronic-stress induced oxidative damage of brain, liver and kidneys in rats. Adv Pharm Bull. 2014;4(Suppl 2):493–499. doi:10.5681/apb.2014.073
   Google Scholar